Metabolic syndrome: a multiplex cardiovascular risk factor
1Center for Human Nutrition, Department of Clinical Nutrition, University of Texas Southwestern Medical Center at Dallas, 5323 Harry Hines Boulevard, Y3.206, Dallas, Texas 75390-9052, USA. Scott.Grundy@UTSouthwestern.edu
The Journal of Clinical Endocrinology and Metabolism
|February 8, 2007
Summary
Metabolic syndrome (MetS) is a key cardiovascular disease risk factor. Identifying MetS aids in early detection, lifestyle intervention, and tailored drug therapy for better patient outcomes.
Area of Science:
- Cardiology
- Metabolic Disorders
- Public Health
Background:
- Metabolic syndrome (MetS) is a significant risk factor for cardiovascular disease.
- It arises from the interaction between obesity and metabolic susceptibility.
Purpose of the Study:
- To evaluate the clinical utility of the metabolic syndrome (MetS) construct.
- To highlight the advantages of identifying MetS in clinical practice.
Main Methods:
- Recognition of MetS based on clustering of clinical measures: waist circumference, blood pressure, triglycerides, HDL, and glucose.
- Review of the impact of MetS identification on clinical practice and research.
Main Results:
- Identification of MetS reveals individuals at increased cardiovascular risk.
- Diagnosis prompts greater clinical focus on obesity and lifestyle factors, reinforcing lifestyle modification efficacy.
- Informs therapeutic decisions for dyslipidemia, hypertension, hyperglycemia, and aspirin prophylaxis.
Conclusions:
- Metabolic syndrome is a clinically useful, multiplex cardiovascular risk factor.
- Its recognition drives advances in diagnosing and treating a major cause of cardiovascular disease.
- It stimulates research and the development of novel multi-target therapies.
Related Concept Videos
01:30Coronary Artery Disease I: Introduction
Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
01:26Type II Diabetes I: Introduction
Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...
01:24Obesity
The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in adipocytes...
01:24Overview of Lipid Metabolism
Lipid metabolism is a crucial process in the human body that involves the synthesis and degradation of lipids. This process is essential for energy production, cell membrane formation, and hormone production, among other functions.
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
01:20Blood Studies for Cardiovascular System I: Cardiac Biomarkers
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
01:26Atherosclerosis III: Management
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...